164 related articles for article (PubMed ID: 11041115)
1. Urinary excretion of platinum in chemotherapy-treated long-term survivors of testicular cancer.
Gerl A; Schierl R
Acta Oncol; 2000; 39(4):519-22. PubMed ID: 11041115
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
Hohnloser JH; Schierl R; Hasford B; Emmerich B
Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
[TBL] [Abstract][Full Text] [Related]
3. Long-term platinum excretion in patients treated with cisplatin.
Schierl R; Rohrer B; Hohnloser J
Cancer Chemother Pharmacol; 1995; 36(1):75-8. PubMed ID: 7720180
[TBL] [Abstract][Full Text] [Related]
4. [Long-term side effects of chemotherapy for testicular cancer].
Kawai K
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1300-5. PubMed ID: 12146015
[TBL] [Abstract][Full Text] [Related]
5. Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors.
Boer H; Proost JH; Nuver J; Bunskoek S; Gietema JQ; Geubels BM; Altena R; Zwart N; Oosting SF; Vonk JM; Lefrandt JD; Uges DR; Meijer C; de Vries EG; Gietema JA
Ann Oncol; 2015 Nov; 26(11):2305-10. PubMed ID: 26347114
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors.
Ishioka J; Fujii Y; Kageyama Y; Fukuda H; Higashi Y; Kihara K
Int J Urol; 2008 Jul; 15(7):642-5. PubMed ID: 18643784
[TBL] [Abstract][Full Text] [Related]
7. Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors.
Hjelle LV; Gundersen POM; Hellesnes R; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Bremnes RM; Haugnes HS
Acta Oncol; 2018 Oct; 57(10):1392-1400. PubMed ID: 29775128
[TBL] [Abstract][Full Text] [Related]
8. Testicular cancer survivorship: research strategies and recommendations.
Travis LB; Beard C; Allan JM; Dahl AA; Feldman DR; Oldenburg J; Daugaard G; Kelly JL; Dolan ME; Hannigan R; Constine LS; Oeffinger KC; Okunieff P; Armstrong G; Wiljer D; Miller RC; Gietema JA; van Leeuwen FE; Williams JP; Nichols CR; Einhorn LH; Fossa SD
J Natl Cancer Inst; 2010 Aug; 102(15):1114-30. PubMed ID: 20585105
[TBL] [Abstract][Full Text] [Related]
9. Serum creatinine and cholesterol levels of testicular cancer patients in long-term follow up.
Hisamatsu E; Kawai K; Hinotsu S; Miyanaga N; Shimazui T; Akaza H
Int J Urol; 2005 Aug; 12(8):751-6. PubMed ID: 16174050
[TBL] [Abstract][Full Text] [Related]
10. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
[TBL] [Abstract][Full Text] [Related]
11. Long-term complications of platinum-based chemotherapy in testicular cancer survivors.
Oh JH; Baum DD; Pham S; Cox M; Nguyen ST; Ensor J; Chen I
Med Oncol; 2007; 24(2):175-81. PubMed ID: 17848741
[TBL] [Abstract][Full Text] [Related]
12. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
13. Adsorptive voltametry to determine platinum levels in plasma from testicular cancer patients treated with cisplatin.
Gelevert T; Messerschmidt J; Meinardi MT; Alt F; Gietema JA; Franke JP; Sleijfer DT; Uges DR
Ther Drug Monit; 2001 Apr; 23(2):169-73. PubMed ID: 11294519
[TBL] [Abstract][Full Text] [Related]
14. Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study.
Hjelle LV; Gundersen PO; Oldenburg J; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Bremnes RM; Haugnes HS
Anticancer Res; 2015 Mar; 35(3):1619-25. PubMed ID: 25750319
[TBL] [Abstract][Full Text] [Related]
15. Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer.
Gietema JA; Meinardi MT; Messerschmidt J; Gelevert T; Alt F; Uges DR; Sleijfer DT
Lancet; 2000 Mar; 355(9209):1075-6. PubMed ID: 10744098
[TBL] [Abstract][Full Text] [Related]
16. Platinum exposure and cause-specific mortality among patients with testicular cancer.
Groot HJ; van Leeuwen FE; Lubberts S; Horenblas S; de Wit R; Witjes JA; Groenewegen G; Poortmans PM; Hulshof MCCM; Meijer OWM; de Jong IJ; van den Berg HA; Smilde TJ; Vanneste BGL; Aarts MJB; Jóźwiak K; van den Belt-Dusebout AW; Gietema JA; Schaapveld M
Cancer; 2020 Feb; 126(3):628-639. PubMed ID: 31730712
[TBL] [Abstract][Full Text] [Related]
17. Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer.
Sprauten M; Darrah TH; Peterson DR; Campbell ME; Hannigan RE; Cvancarova M; Beard C; Haugnes HS; Fosså SD; Oldenburg J; Travis LB
J Clin Oncol; 2012 Jan; 30(3):300-7. PubMed ID: 22184390
[TBL] [Abstract][Full Text] [Related]
18. Long-term toxicity of cisplatin in germ-cell tumor survivors.
Chovanec M; Abu Zaid M; Hanna N; El-Kouri N; Einhorn LH; Albany C
Ann Oncol; 2017 Nov; 28(11):2670-2679. PubMed ID: 29045502
[TBL] [Abstract][Full Text] [Related]
19. Treatment of poor prognosis nonseminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regimen.
Ozols RF; Deisseroth AB; Javadpour N; Barlock A; Messerschmidt GL; Young RC
Cancer; 1983 May; 51(10):1803-7. PubMed ID: 6187426
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome.
Bucher-Johannessen C; Page CM; Haugen TB; Wojewodzic MW; Fosså SD; Grotmol T; Haugnes HS; Rounge TB
Clin Epigenetics; 2019 Dec; 11(1):179. PubMed ID: 31796056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
